Skip to main content
. 2013 Sep 24;38(5):689–697. doi: 10.1038/ijo.2013.149

Figure 4.

Figure 4

Mean (analysis of covariance) changes (positive=improved) in quality-of-life scores (IWQoL-Lite) among individuals on liraglutide 3.0 mg at 20 weeks, in individuals with or without at least one episode of nausea or vomiting (intention-to-treat population with the last observation carried forward). IWQoL-Lite scores ranged from 0 (worst) to 100 (best).